These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 38920202

  • 1. Thiazide and thiazide-like diuretics are associated with improved cardiovascular and renal outcomes in patients with chronic kidney disease.
    Lin HY, Chang YH, Wang YT, Liang PI, Hung CC, Chang JM, Dai DF, Lin CS, Chang KT.
    Ann Acad Med Singap; 2023 Oct 30; 52(10):510-521. PubMed ID: 38920202
    [Abstract] [Full Text] [Related]

  • 2. Thiazide diuretics versus loop diuretics in stage 3-5 CKD: impact on cardiorenal outcomes.
    Sung LC, Chiu HW, Yu SM, Tsou LL, Hsu YH, Wu MS, Lin CL, Tsai FJ, Chou CL.
    Postgrad Med; 2024 Sep 30; 136(7):738-748. PubMed ID: 39189768
    [Abstract] [Full Text] [Related]

  • 3. Prognostic Effect of Isolated Nocturnal Hypertension in Chinese Patients With Nondialysis Chronic Kidney Disease.
    Wang C, Li Y, Zhang J, Ye Z, Zhang Q, Ma X, Peng H, Lou T.
    J Am Heart Assoc; 2016 Oct 10; 5(10):. PubMed ID: 27792646
    [Abstract] [Full Text] [Related]

  • 4. Impact of chronic kidney disease and end-stage renal disease on the mid-term adverse outcomes in diabetic patients with cardiovascular diseases.
    Chou CL, Chiu HW, Hsu YH, Yu SM, Liou TH, Sung LC.
    Sci Rep; 2024 Jul 09; 14(1):15770. PubMed ID: 38982230
    [Abstract] [Full Text] [Related]

  • 5. Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.
    Toth-Manikowski SM, Yang W, Appel L, Chen J, Deo R, Frydrych A, Krousel-Wood M, Rahman M, Rosas SE, Sha D, Wright J, Daviglus ML, Go AS, Lash JP, Ricardo AC, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.
    Am J Kidney Dis; 2021 Aug 09; 78(2):200-209.e1. PubMed ID: 33857532
    [Abstract] [Full Text] [Related]

  • 6. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease.
    McClellan WM, Langston RD, Presley R.
    J Am Soc Nephrol; 2004 Jul 09; 15(7):1912-9. PubMed ID: 15213281
    [Abstract] [Full Text] [Related]

  • 7. Association between the risk of heart failure hospitalization and end-stage renal disease with digoxin usage in patients with cardiorenal syndrome: A population-based study.
    Chang KT, Kuo HF, Chang YH, Wang YT, Yang LJ, Niu SW, Kuo IC, Chen Y, Wen ZH, Hung CC, Chang JM, Lin HY.
    Front Public Health; 2022 Jul 09; 10():1074017. PubMed ID: 36733284
    [Abstract] [Full Text] [Related]

  • 8. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL, Knoll GA, Petrcich W, Hiremath S, Ruzicka M, Burns KD, Edwards C, Bugeja A, Rhodes E, Sood MM.
    Am J Kidney Dis; 2021 Feb 09; 77(2):178-189.e1. PubMed ID: 32920153
    [Abstract] [Full Text] [Related]

  • 9. Impact of Acute and Chronic Kidney Disease on Heart Failure Hospitalizations After Acute Myocardial Infarction.
    Yandrapalli S, Christy J, Malik A, Wats K, Harikrishnan P, Aronow W, Frishman W.
    Am J Cardiol; 2022 Feb 15; 165():1-11. PubMed ID: 34893301
    [Abstract] [Full Text] [Related]

  • 10. Predictors and Outcomes of Health-Related Quality of Life in Adults with CKD.
    Porter AC, Lash JP, Xie D, Pan Q, DeLuca J, Kanthety R, Kusek JW, Lora CM, Nessel L, Ricardo AC, Wright Nunes J, Fischer MJ, CRIC Study Investigators.
    Clin J Am Soc Nephrol; 2016 Jul 07; 11(7):1154-1162. PubMed ID: 27246012
    [Abstract] [Full Text] [Related]

  • 11. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
    Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, Parving HH, Parfrey P, Singh AK, Burdmann EA, Levey AS, Eckardt KU, McMurray JJV, Weinrauch LA, Liu J, Claggett B, Lewis EF, Pfeffer MA.
    Diabetes Obes Metab; 2019 May 07; 21(5):1199-1208. PubMed ID: 30672083
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N, Xie D, Sha D, Appel LJ, Deo R, Feldman HI, He J, Jamerson K, Kusek JW, Messe S, Navaneethan SD, Rahman M, Ricardo AC, Soliman EZ, Townsend R, Go AS.
    J Am Soc Nephrol; 2018 Dec 07; 29(12):2859-2869. PubMed ID: 30377231
    [Abstract] [Full Text] [Related]

  • 13. Association between chronic kidney disease progression and cardiovascular disease: results from the CRIC Study.
    Rahman M, Xie D, Feldman HI, Go AS, He J, Kusek JW, Lash J, Miller ER, Ojo A, Pan Q, Seliger SL, Steigerwalt S, Townsend RR, CRIC Study Investigators.
    Am J Nephrol; 2014 Dec 07; 40(5):399-407. PubMed ID: 25401485
    [Abstract] [Full Text] [Related]

  • 14. Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events: a nationwide follow-up study during 1998-2009.
    Chang YT, Wu JL, Hsu CC, Wang JD, Sung JM.
    Diabetes Care; 2014 Dec 07; 37(1):277-85. PubMed ID: 23920086
    [Abstract] [Full Text] [Related]

  • 15. Coronary Artery Calcification and Risk of Cardiovascular Disease and Death Among Patients With Chronic Kidney Disease.
    Chen J, Budoff MJ, Reilly MP, Yang W, Rosas SE, Rahman M, Zhang X, Roy JA, Lustigova E, Nessel L, Ford V, Raj D, Porter AC, Soliman EZ, Wright JT, Wolf M, He J, CRIC Investigators.
    JAMA Cardiol; 2017 Jun 01; 2(6):635-643. PubMed ID: 28329057
    [Abstract] [Full Text] [Related]

  • 16. Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease: A Nationwide Population-Based Cohort Study.
    Lin CS, Chen SJ, Sung CC, Lin CL, Lin SH, Cheng SM, Wang IK, Huang WS, Kao CH.
    Medicine (Baltimore); 2015 Jul 01; 94(28):e1164. PubMed ID: 26181560
    [Abstract] [Full Text] [Related]

  • 17. Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study.
    Fitzpatrick JK, Yang J, Ambrosy AP, Cabrera C, Stefansson BV, Greasley PJ, Patel J, Tan TC, Go AS.
    BMJ Open; 2022 Jan 31; 12(1):e048755. PubMed ID: 35105612
    [Abstract] [Full Text] [Related]

  • 18. Chronic Kidney Disease and Health Status Outcomes Following Acute Myocardial Infarction.
    Navarro MA, Gosch KL, Spertus JA, Rumsfeld JS, Ho PM.
    J Am Heart Assoc; 2016 May 23; 5(5):. PubMed ID: 27217497
    [Abstract] [Full Text] [Related]

  • 19. Warfarin Use and Increased Mortality in End-Stage Renal Disease.
    Lin MC, Streja E, Soohoo M, Hanna M, Savoj J, Kalantar-Zadeh K, Lau WL.
    Am J Nephrol; 2017 May 23; 46(4):249-256. PubMed ID: 28910806
    [Abstract] [Full Text] [Related]

  • 20. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 23; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.